The degradation of chondroitin 4-[35S]sulphate isolated from chick-embryo cartilage was studied in the rat by experiments on free-range animals, on wholly anaesthetized animals with ureter cannulae, by perfusion of isolated liver, by whole-body radioautography and by isolation of liver lysosomes. After injection into rats 68 % of the radioactivity was recovered in the urine after 24h, approximately one-half of this being in the form of lowmolecular-weight material, chiefly inorganic sulphate. Cannulation experiments demonstrated that the proportion of low-molecular-weight components excreted in the urine increased with time until, after 12h, virtually all was inorganic sulphate. Whole-body radioautography identified the liver as the major site of radioisotope accumulation after injection of labelled polysaccharide. Perfusion through isolated liver indicated that this organ has the ability to metabolize the polymer with the release of low-molecular-weight products, principally inorganic sulphate. Incubation of a lysosomal fraction prepared from rat liver after injection of chondroitin 4-[35S]sulphate gave rise to degradation products of low molecular weight, and experiments in vitro with rat liver lysosomes confirmed that these organelles are capable of the entire degradative process from chondroitin sulphate to free inorganic sulphate.
It is thought that chondroitin sulphate chains attached to peptide are released from proteoglycans in the tissues by the proteolytic action of cathepsins (Dingle et al., 1971; Wasteson et al., 1972) . Further degradation of the polysaccharide-peptides probably takes place at sites removed from their tissue oforigin. Evidence for other sites of accumulation and possibly degradation stems from the work of Aronson & Davidson (1968) , who showed that 1 % of an injected dose of chondroitin [35S] sulphate becomes concentrated in liver lysosomes after 15min and is subsequently removed within 4 days.
Various reports on the extent of degradation of circulating chondroitin sulphate (Dohlman, 1956; Dziewiatkowski, 1956) show that inorganic [35S]_ sulphate appears in the urine after the administration of 3S-labelled polysaccharide. However, Revell & Muir (1972) have shown by bladder-irrigation techniques that chondroitin 4-sulphate can be excreted in an undegraded form after intravenous injection. Tudball & Davidson (1969) suggest that an enzyme system associated with rat liver lysosomes is in part responsible for the turnover in vivo of the ester sulphate group of chondroitin 4-sulphate, but no sulphatase activity was revealed by Dohlman (1956) , who incubated various rat tissue homogenates with labelled chondroitin sulphate.
This study has been undertaken, by using a variety of physiological techniques to supplement studies Vol. 134 in vitro, to establish the site and extent of degradation of chondroitin 4-sulphate in the rat.
Materials and Methods General techniques
Analytical methods. Hexuronic acid was determined by the method of Bitter & Muir (1962) with glucuronolactone as standard. Amino acid composition was determined by using a Technicon amino acid analyser after hydrolysis in 6M-HCl at 1 10°C for 24h in vacuo, and hexosamines were similarly determined after hydrolysis in 4M-HCI at 100°C for 8 h. Ester sulphate was assayed by the method ofWessler (1971) .
Electrophoresis. Electrophoresis on cellulose acetate strips (Millipore Ltd., Bedford, Mass., U.S.A., 12cm x 2.5 cm) was performnd at constant voltage of 250V for 40min in acetic acid-pyridine-water (20:1:179, by vol.) at pH3.1. The strips were stained with aq. 0.5 % Toluidine Blue (BDH Chemicals Ltd., Poole, Dorset, U.K.) and scanned by using a JoyceLoebl Strip-Scanner in reflectance operation.
Electrophoresis on paper (Whatman no. 1; 46cm x 2.5cm) was performed at constant voltage of 250V for 2h in 0.1 M-sodiunm acetate-acetic acid buffer, pH4.6.
Radioactive spots were detected by scanning cellulose acetate or paper strips with a model 7201 Packard Radiochromatogram Scanner in 47T operation under gas flow. Radioactive zones were also detected by radioautography with X-ray film (Ilford Industrial grade B) for periods of up to 10 days. Radioactivity counting. A small volume (25-250,u1) of each sample was added to 10ml of a scintillation mixture (14g of 2,5-diphenyloxazole and 400ml of 2-methoxyethanol made to 2 litres with toluene) and counted for radioactivity in a Packard Tri-Carb liquid-scintillation spectrometer. The recorded counts were corrected for quenching and the background count eliminated by counting an appropriate portion of control urine, plasma, bile or eluent for radioactivity. When whole-blood samples or lysosomal fractions were counted for radioactivity the material was added to Hyamine hydroxide 10-X (Packard Instrument Co. Inc., Downers Grove, Ill., U.S.A.), digested at 37°C for 16h, neutralized with 2M-HCI, and a portion was counted in the usual way.
Gel chromatography. Samples (200, u) of the injected material, urine, plasma or lysosome supernatant solutions were loaded on to a column (550mm x 9mm) of Sephadex G-200 (Pharmacia Ltd., London W.5, U.K.) and eluted with 0.2M-NaCl at a flow rate of 4ml/h. Fractions (1 ml) were collected and 100,ul portions removed for measurement of radioactivity. (Aronson & Davidson, 1968) by injecting 10-day-fertilized hens' eggs with 440,uCi of carrier-free Na235SO4 (The Radiochemical Centre, Amersham, Bucks., U.K.)/egg. After a further 4 days incubation the embryos were separated from the rest of the egg contents and the cartilage ofthe long bones and wings was dissected free and subjected to papain digestion (Scott, 1960) . Glycosaminoglycans were isolated from the soluble digest by the use of mixture of Amberlite cation-exchange resins [IRC 50 and IR 120 (H+ forms) (BDH Chemicals Ltd.), 1:1, w/w] to remove residual protein followed by chromatography on Dowex 1 (X2; Cl-form; 20040 mesh) (Mason & Wusteman, 1970) . The chondroitin sulphate fraction was eluted from this resin by 2M-NaCl and then precipitated by 3.5vol. ofethanol. The mixed chondroitin sulphates were further fractionated by precipitation with ethanol as calcium salts (Meyer et al., 1956 ). The fraction precipitated by 30-40% (v/v) ethanol was converted into the sodium salt bypassage through cation-exchange resin, reprecipitated with ethanol and freed from all traces of inorganic sulphate by passage through a column of Sephadex G-25 (fine grade; Pharmacia Ltd.). The unretarded peak, which was stored frozen at -20°C, had a specific radioactivity of 4.54,Ci/,mol of uronic acid. Whole-body radioautography. Whole-body radioautography was carried out as described by Powell et al. (1967) on 1-month-old Medical Research Council hooded rats which had been injected with chondroitin 4-[35S]sulphate (2.7,uCi/animal) via the penal vein while under light ether anaesthesia. The rats were killed at time-intervals ranging from 30min to 24h after injection.
Perfusion of isolated liver. A liver (12.5g) from a Medical Research Council hooded rat (350g) was perfused in an apparatus similar to that described by Curtis et al. (1970) with whole blood (from Wistar rats) containing 33.4pCi of chondroitin 4-[35S]_ sulphate in 120ml of perfusate. Samples (2ml) of blood were removed from the apparatus at intervals and the plasma was assayed for total radioactivity and stored at -20°C until analysed by gel chromatography and by paper electrophoresis.
Cannulation ofureters andbile duct. A male Medical Research Council hooded rat (360g) was anaesthetized with ether and the trachea exposed and cannulated. The right jugular vein was then cannulated towards the heart and phenobarbitone sodium British Veterinary Codex (Nembutal; Abbot Laboratories Ltd., Queenborough, Kent, U.K.), dissolved in 0.95% NaCl, was administered via the jugular-vein cannula at a dose of 20mg/kg body wt. Similar doses of phenobarbitone were administered 1973 as necessary to maintain anaesthesia throughout the experiment. The ureters and bile duct were cannulated through a midline abdominal incision and urine and bile samples were collected in tared containers (cooled by ice) at intervals of 2h. After the collection ofurine and bile to act as controls, thejugular vein was used for administration of 3.3,uCi of chondroitin 4-(35S]sulphate. At 8h after administration of the labelled polymer, the rat was given small amounts (1 ml/h) of a 5 % solution of D-glucose in 0.95% NaCl. Each urine and bile sample was assayed for total radioactivity, then stored at -20°C until the urine samples were examined for degradation products by paper electrophoresis and by gel chromatography on Sephadex G-200 (5.6, uCi) , and a lysosomerich fraction was isolated from the liver, by the method of Davies et al. (1971) 1 h after the animal was killed, and incubated in 20ml of 0.01 M-Tris-acetate buffer, pH7.4, containing 0.25M-sucrose at 24°C. Samples (5ml) were removed at intervals from the incubation mixture and a portion (100,ul) was assayed for total radioactivity. The remaining portion was centrifuged at 16500g for 20min, the supernatant was poured off, and the remaining pellet was resuspended in 0.01 M-Tris-acetate buffer, pH7.4. The supernatant fractions were then assayed for radioactivity and a 7h supernatant fraction was freezedried and the resulting concentrated solution fractionated by gel filtration on Sephadex G-200.
Lysosomal experiments in vitro. Lysosomes were prepared from the livers of Medical Research Council hooded rats by a modification of the method of de Duve et al. (1955) and disrupted by freezing and thawing (eight cycles). This extract was incubated with chondroitin 4-[35S]sulphate at 37°C in 22mln of 0.1M-sodium acetate buffer, pH4.55, and 3ml samples were removed at intervals and fractionated into polymer, a fraction assumed to be oligosaccharide and inorganic sulphate by precipitation with cetylpyridinium chloride and BaCl2 (Wood et al., 1973) .
Results

Experiments on free-range animals
Of the radioactivity injected into free-range animals, 71 % was recovered in the urine collected over 72h but the majority (68 %.) was excreted in 24h. The results ofgel chromatography ofthe 24h urine sample on Sephadex G-200 are shown in Fig. 1 . Analysis of the elution profiles indicated there was little or no difference between that of chondroitin 4-[35S]sulphate and of the radioactive component of higher molecular weight in the urine. The peak of lower molecular weight (52% of total radioactivity) was studied further by freeze-drying pooled fractions and subjecting them to paper electrophoresis.
The (Fig. 1) , presumably owing to slight degradation of the type reported by Revell & Muir (1972) . Whole-body radioautography At 30min after injection a general distribution of radioactivity throughout the body was seen and a considerable amount was found in blood (Plate 1). The liver showed the most striking uptake of radioactivity, with the large hepatic veins and other blood spaces being virtually devoid of label; this suggests rapid uptake by the parenchyma and consequent fall in the blood concentrations 1 h after injection (Plate lb). At this time accumulation in the small intestine was observed, suggesting some biliary excretion of the label. At 2h after administration the amount of radioactivity in the body, and particularly in the liver, had fallen simultaneously with the appearance of radioactivity in the bladder. After 3 and 4h the radioactive content of the body was even lower and the major area of accumulation was the small intestine. A similar pattern was seen after 6.5 h, but the accumulation in the gastrointestinal tract was found in the large intestine. The longest time-interval between injection and killing was 24h. At this stage faint areas of accumulation of radioactivity were seen in the epiphyseal plates of long bones, an indication of inorganic [35S]sulphate in the circulation.
Liver perfusion
The progressive degradation of perfused chondroitin 4-sulphate was studied by gel filtration of samples of plasma removed from the liver at intervals of up to 6h. Fig. 2 shows that 3.3mg of the polymer was 25 % desulphated after 6h perfusion. Further incubation of blood samples removed from the liver gave no further release of inorganic sulphate, indi- 
Cannulation ofureters and bile duct
Of the injected radioactivity 72 % was recovered in the urine and 3% in the bile after 12 h. Fig. 2 also shows that 0.33mg of the polymer yielded only inorganic sulphate in the urine after 6h had elapsed. The peak of labelled material of higher molecular weight was again indistinguishable from that of the starting material.
Lysosomal experiments in vivo
The supernatant from the lysosomal fraction obtained from the liver of animals injected with labelled chondroitin sulphate contained radioactivity that was released from the insoluble fractions over the course of 6h incubation (Fig. 3) (Fig. 4) . When incubated for a further 4h at 37°C, degradation had decreased the amount of polymer to 14%, oligosaccharide to 51 % and inorganic sulphate to 36 % of the original dose. 4-sulphatefrom rat liver lysosomes labelled in vivo The lysosome-rich fraction was isolated from rats 1 h after intravenous injection of 5.6,uCi of chondroitin 4-[35S]sulphate and samples were removed during incubation at 24°C in 0.01 M-Tris-acetate buffer, pH7.4, containing 0.25M-sucrose. These samples were centrifuged and the supernatant was examined for degradation products (retarded peak in Fig. 1 Time (h) Fig. 4 . Time-course of degradation of 35S-labelled chondroitin 4-sulphate when incubated with a rat liver lysosome preparation in vitro Samples were removed at intervals and fractionated into intact polymer (a) (precipitated by cetylpyridinium chloride), inorganic sulphate (A) (precipitated by BaCl2) and oligosaccharide (o) (precipitated by neither).
Discussion
As reported by Revell & Muir (1972) in studies on guinea pig, a substantial proportion of 35S-labelled chondroitin 4-sulphate is eliminated from the circulation of the rat in a largely undegraded form. In the present paper the site of degradation of the remaining chondroitin sulphate has been pinpointed, hence accounting for the inorganic 3"S-labelled sulphate also found in the urine after injection of labelled polymer. No other site of accumulation apart from the liver was detected by radioautography. Perfusion and cannulation of this organ indicated that the liver ofone rat could theoretically degrade 0.8 mg ofchondroitin sulphate in 6h. Thus over a period of 10 days (the approximate half-life of chondroitin sulphate proteoglycan; Wasteson et al., 1972 ) the rat liver is capable of handling 32mg of chondroitin sulphate. Together with urinary excretion this should account for the turnover of all rat chondroitin sulphate. Confirmation of this suggestion has been provided by experiments with hepatectomized rats (Wood et al., 1973) , in which it has been shown that removal of the liver decreases degradation to control values.
Once in the liver lysosomes the chondroitin sulphate is presumably subjected to the degradation sequence of hyaluronidase, ,-glucuronidase and ,B-Nacetylhexosaminidase with lysosomal sulphatase, as described by Tudball & Davidson (1969) , acting at the level of oligosaccharide sulphate to release inorganic sulphate, which is subsequently reused orexcreted via the kidneys.
Though the present study clearly establishes the fate of slightly undersulphated chondroitin sulphate chains that are virtually free of peptide and still polymeric, the situation in vivo may be more complex. Intracellular degradation ofthe polysaccharide chains together with extensive desulphation within the cartilage has been reported by Wasteson et al. (1972) for a portion of chondroitin sulphate of cartilage labelled in tissue culture. The bulk of chondroitin sulphate released by normal turnover from cartilage and other connective tissues is probably in the form of proteoglycan partially degraded by cathepsin D (Dingle et al., 1971) and so includes substantial amounts of peptide. This may affect uptake by liver lysosomes, but Calatroni et al. (1969) have detected free polysaccharide chains in the human plasma, so a mechanism clearly exists for further proteolytic digestion to yield chondroitin sulphate chains similar to those used in this study.
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